Shares of Craneware plc (LON:CRW – Get Free Report) traded up 2.2% during trading on Tuesday. The company traded as high as GBX 1,056 and last traded at GBX 1,030. Approximately 862,850 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 657,188 shares. The stock had previously closed at GBX 1,008.
Analysts Set New Price Targets
Separately, Berenberg Bank decreased their price objective on Craneware from GBX 2,600 to GBX 1,600 and set a “buy” rating on the stock in a report on Monday, September 21st. Three analysts have rated the stock with a Buy rating. According to MarketBeat, Craneware currently has a consensus rating of “Buy” and an average price target of GBX 1,673.33.
View Our Latest Report on Craneware
Craneware Price Performance
The stock has a market cap of £354.17 million, a P/E ratio of 18.39 and a beta of 0.28. The company has a current ratio of 0.83, a quick ratio of 1.00 and a debt-to-equity ratio of 14.60. The company’s fifty day simple moving average is GBX 1,134.99 and its 200-day simple moving average is GBX 1,340.16.
Insider Activity
In related news, insider Craig Preston sold 14,656 shares of the stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of GBX 1,035, for a total value of £151,689.60. Also, insider Susan Nelson purchased 1,408 shares of the company’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was acquired at an average cost of GBX 1,054 per share, with a total value of £14,840.32. 10.37% of the stock is currently owned by insiders.
Craneware Company Profile
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster – that simplify the complexities of healthcare finance and operations.
See Also
- Five stocks we like better than Craneware
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.
